Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • World
  • Users
  • Groups
Skins
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (Zephyr)
  • No Skin
Collapse
Peptide Critic Community

Peptide Critic Community

  1. Randy the Rats Research Forum
  2. Peptide Discussion
  3. Drowning in glp options. With nothing new in sight.
Prize
Red, White & Blue V2 Pens
Ends in
8161 entries · 1000 participants
Enter →

Drowning in glp options. With nothing new in sight.

Scheduled Pinned Locked Moved Peptide Discussion
survodutideresearchingother-peptidestack
4 Posts 2 Posters 208 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • quicksilver80Q Offline
    quicksilver80Q Offline
    quicksilver80
    wrote last edited by quicksilver80
    #1

    This isnt exactly a critique on the pep community but more of a confusion as to why theres a draw to going to another glp with the same agonism pathway. My mindset was to always look for more. Whereas alot of the average peptide researcher looks for more of the same.

    Like sure. Tirz to reta makes sense. You got the glucagon agonist and more effects.
    Ghetto reta, stopgap for people trying to get same effects with different chems. Got it. Totally get the mindset.
    I understand some people dont react well with reta but do great with tirz. Fine. Totally get that.

    But now we got 15 new ones? With no novel distinctions? Dont you think compounders should focus efforts elsewhere instead of making another ozempic with a silly name? Is there a community or circle of people im not privy to that is looking for the next big thing. Not just the next same damn thing? Should i seek biohackers instead?Anyone else? Anything you heard of outside of the regular humdrum? Has any of the compounders knocked off the quad or quint agonist yet?

    1 Reply Last reply
    0
    • R Online
      R Online
      ResearchCat
      wrote last edited by
      #2

      IMO, you are overthinking it. 90% of people are needle averse. injectables need to be stored cold and carefully. A pill and lower insurance costs will expand adoption by a very large amount around the world. Different people have different reactions and effectiveness. The new offerings should give a much larger group of people the ability to access GLP-1’s the way they want and need to which should be great for society overall and decrease health care costs.

      Please set a funny and sarcastic signature line. It brings me joy. Thank you for your attention in this matter.

      quicksilver80Q 1 Reply Last reply
      2
      • R ResearchCat

        IMO, you are overthinking it. 90% of people are needle averse. injectables need to be stored cold and carefully. A pill and lower insurance costs will expand adoption by a very large amount around the world. Different people have different reactions and effectiveness. The new offerings should give a much larger group of people the ability to access GLP-1’s the way they want and need to which should be great for society overall and decrease health care costs.

        quicksilver80Q Offline
        quicksilver80Q Offline
        quicksilver80
        wrote last edited by
        #3

        @ResearchCat i guess i should have made it more clear that this is more of a our community kind of conversation and not for the regular masses. Since this group isnt "normal"

        1 Reply Last reply
        1
        • R Online
          R Online
          ResearchCat
          wrote last edited by
          #4

          Yeah, I almost mentioned that we are not the target audience for most of this stuff. Some of it might be useful down the road, like when there is a cheap once a month NA-931 pill - assuming that works as advertised.

          There are some treatments for LP(a) in various stages of clinical trials that are twice a year injections that completely shut down your body’s production of LP(a). (alipoprotein a is a cholesterol type protein that causes very high risk of heart disease and stroke and is almost purely genetic.). There are a lot of really interesting RNA and other type drugs coming.

          Please set a funny and sarcastic signature line. It brings me joy. Thank you for your attention in this matter.

          1 Reply Last reply
          1

          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

          With your input, this post could be even better 💗

          Register Login
          Reply
          • Reply as topic
          Log in to reply
          • Oldest to Newest
          • Newest to Oldest
          • Most Votes


          • Login

          • Login or register to search.
          • First post
            Last post
          0
          • Categories
          • Recent
          • Tags
          • Popular
          • World
          • Users
          • Groups